Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous ex-vivo-expanded leucocytes treated with 5-aza-2’-deoxycytidine

EU orphan designation number: EU/3/13/1197   
Active ingredient: Autologous ex-vivo-expanded leucocytes treated with 5-aza-2’-deoxycytidine
Indication: Treatment of glioma
Sponsor: CytoVac A/S
Venlighedsvej 6, DK-2970 Hørsholm, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/086/13 (2013)8042 of 13/11/2013